Author:
Li Sen-lin,Zhou Hong,Liu Jia,Yang Jian,Jiang Li,Yuan Hui-min,Wang Meng-heng,Yang Ke-shan,Xiang Ming
Publisher
Springer Science and Business Media LLC
Reference39 articles.
1. Chakkera HA, Kudva Y, Kaplan B. Calcineurin inhibitors: pharmacologic mechanisms impacting both insulin resistance and insulin secretion leading to glucose dysregulation and diabetes mellitus. Clin Pharmacol Ther. 2017;101:114–20.
2. Ling Q, Huang H, Han Y, Zhang C, Zhang X, Chen K, et al. The tacrolimus-induced glucose homeostasis imbalance in terms of the liver: From bench to bedside. Am J Transpl. 2020;20:701–13.
3. Rodriguez-Peralvarez M, Colmenero J, Gonzalez A, Gastaca M, Curell A, Caballero-Marcos A, et al. Cumulative exposure to tacrolimus and incidence of cancer after liver transplantation. Am J Transpl. 2022;22:1671–82.
4. Mizuta K, Kobayashi E, Uchida H, Fujimura A, Kawarasaki H, Hashizume K. Influence of tacrolimus on bile acid and lipid composition in continuously drained bile using a rat model. Comparative study with cyclosporine. Transpl Int. 1999;12:316–22.
5. Cofan F, Cofan M, Campos B, Guerra R, Campistol JM, Oppenheimer F. Effect of calcineurin inhibitors on low-density lipoprotein oxidation. Transpl Proc. 2005;37:3791–3.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献